5 Stocks To Buy In An Overvalued Market

5 Stocks To Buy In An Overvalued Market

Analysé Voir sur YouTube Demandé Le
Rendement de la vidéo
Appels
5
Achat / Vente
5 0
Publié

Recommandations

L'entrée est le cours de clôture de l'actif à la date de publication. Le cours actuel est la dernière clôture enregistrée.

  1. 01 JRSH NASDAQ ACHETER +0,00%
    Entrée $5,42 29 août 2026
    Actuel $5,42 28 août 2026
    Résultat +$0,00

    Indeed, Geron is part of that elite tier of A-rated stocks, which means a strong buy recommendation.

  2. 02 SHIP NASDAQ ACHETER +0,00%
    Entrée $17,79 29 août 2026
    Actuel $17,79 28 août 2026
    Résultat +$0,00

    the lone analyst covering the stock is giving a strong buy recommendation that includes a fair value price target pointing to nearly 50% upside in the year ahead.

    Contexte Now, let's move on to our second value stock in Seanergy Maritime with a symbol of SHIP. ... the lone analyst covering the stock is giving a strong buy recommendation that includes a fair value price target pointing to nearly 50% upside in the year ahead.

  3. 03 GPRE NASDAQ ACHETER +0,00%
    Entrée $14,66 29 août 2026
    Actuel $14,66 28 août 2026
    Résultat +$0,00

    Now Plains certainly fits the bill.

    Contexte Now, Plains certainly fits the bill.

  4. 04 IRWD NASDAQ ACHETER +0,00%
    Entrée $4,13 29 août 2026
    Actuel $4,13 28 août 2026
    Résultat +$0,00

    This pharma stock may be very good medicine for your portfolio.

  5. 05 ENS NYSE ACHETER +0,00%
    Entrée $185,46 29 août 2026
    Actuel $185,46 28 août 2026
    Résultat +$0,00

    Now, we can snap it up a much more attractive entry point.

Transcription Complète
As the market makes uh new highs, there's a lot more headlines about stocks getting a little bit too expensive. Even some saying a bubble is forming. That's it's a lot harder to find value these days. And gladly today I have found five of them to share with you right now. But not boring value stocks. We still want healthy growth companies with stellar fundamentals that will help us propel shares much, much higher. The combination of growth and value points to great odds of serious outperformance in the months ahead. But do keep tuned all the way to the end as I often save the best stock for last. Okay, we're going to get started with the first of five stocks today in Garash Holdings with the symbol of JRSH. Before I lay out the bullish case for this stock, I want to briefly introduce myself. I'm Steve Reitmeyer, but everyone calls me Righty. I've been investing for over 40 years and currently a partner at wallstreetsurvivor.com where our quant rating system identifies stocks with the highest likelihood to outperform the market. And if you like timely stock market topics like this, then please hit that like button as it tells me to make more videos like this in the future. Okay. Let's get back to Garash Holdings and why it's interesting right now. They manufacture and export sportswear and outerwear. The jackets, the polos, the activewear made for some of the biggest brands and retailers in the world. I know that sounds kind of boring on the surface, but you have to appreciate that this is a turnaround unfolding and a turnaround is one of the better investment opportunities. That starts with 65% revenue growth going back the past 3 years, finally putting them back into the earnings plus column. Now, as we look forward, Wall Street analysts are calling for 26% earnings growth in the year ahead as the turnaround continues to unfold. That is not the only appealing feature. How about the PEG ratio being only 0.92 when the average stock trades 60% higher with a PEG ratio of 1.5? Or how about the appealing share price around $5 a share? Or how about this paying a dividend yield of about 4.65%? And the earnings growth forecast foreshadows even higher dividend payments as we move ahead. Despite all that, it has largely flown under Wall Street's radar. Now, when that is the case, then I lean on the deep dive analysis the Zen Ratings Quant model to explore the pros and cons of any stock. The system overall analyzes every stock across 115 different factors and then distills it down into an intuitive letter grade of A through F. Indeed, you want your portfolio loaded up with A's just like a report card as they have historically outperformed the S&P 500 by nearly 3 to 1 over the years. Indeed, Geron is part of that elite tier of A-rated stocks, which means a strong buy recommendation. That's because across those 115 fundamental and technical factors, it lands in the top 1% of all stocks we track. That means they have a truly special fundamental profile. The 115 factors are then compiled into seven underlying component grades that can give us some clues about the unique strengths and weaknesses of any stock. So, let's see what that says for Geron. We can start with momentum in the top 17% of all stocks. You know, it's always nice to have timely shares. Our proprietary AI factor grade is top 10%. That is where we use AI to measure how likely a stock is to outperform based upon patterns in the data. Sentiment, the smart money indicator, is top 8% of all stocks. Growth, top 7% and the standout grade, which makes a lot of sense in this video today, is value in the top 3% of all stocks. Where I will be straight with you is the size. We are talking about a market cap under 100 million. This means shares are going to be a bit more volatile than your average company. But that is a small amount of risk given truly outsized reward potential. That's because turnarounds typically start with an attractive value proposition. But in the end, it is the outsized growth that propels shares much, much higher. The Zen Ratings says odds that outcome are very high at this time. So, that is our first bargain hiding under the radar given its size. The next stock is hiding in a corner of the market most investors never look and it is a riding a boom that is just getting started. Quick aside before I continue, if you enjoy discovering stocks aligned with current events like this one, then the best thing you can do for yourself right now is sign up for my next live training session this coming Monday. The focus is on timely market insights plus my top picks. Now, it's totally free, but you do need to sign up. Do that now to join me this coming Monday. Just go to wallstreetzen.com/live. Now, let's move on to our second value stock in Seanergy Maritime with a symbol of SHIP. This is a capesize dry bulk shipping company and the timing here is the whole story. For those who don't know, capesize vessels are the giants that haul iron ore and coal across the world's oceans. When demand for those cargoes runs hot and the supply of ships stays tight, the day rates spike and the companies that own the ships get to name their own price. That's exactly the market Seanergy is sitting in right now and it's showing up in their quarterly earnings results. In fact, Seanergy has beaten Wall Street earnings estimates for 20 quarters in a row, which is very difficult for a cyclical company like this. And what it tells you is the management team knows how to run ships through all stages of the economic and shipping cycle. Now, the road ahead looks even brighter as estimates point to earnings growth over 40% a year going forward. This is significantly higher than its industry peers. Now, the best part is you're not overpaying for all that growth as proven by the ultra-low PEG ratio of only 0.42. Remember, anything under one is considered a great value. Therefore, anything under 0.5 is just downright dirt cheap as is Seanergy. Just like our last stock, Wall Street coverage is pretty light. However, it is worth noting the lone analyst covering the stock is giving a strong buy recommendation that includes a fair value price target pointing to nearly 50% upside in the year ahead. The Zen ratings agrees with the bull case for Seanergy as they earned that coveted A rating. Again, we have the ship sailing in the top 1% all stocks, which yes, that means it's better than 99% of the stocks that are out there. The strength of that overall rating shows up loud and clear in the component rates. We can start that story at the top 20% for financial strength. That's a tough one for uh cyclical companies to do. It tells you they are incredibly well-run company. The AI timeless factors top 16% growth top 15% sentiment top 7% momentum top 5% and if that wasn't good enough, how about top 1% for value? Not just the PEG ratio, but determine after looking across 21 different value measures. Okay, the honest catch here is the economic and shipping cycle. Meaning shipping rates rise and fall and right now they're clearly on the rise. But if it backslides even just a little bit, shares will feel that pressure quite quickly. But right now, the trend is most certainly ships friend pointing to outside growth ahead. Now add on top the large discount to fair value. Thus, if the growth continues to sail in and expect a large cargo haul of profits coming to your port. folio that is. Yeah, sorry I couldn't help myself. Before I get to our third stock, I want to know if you are finding value in this video. If so, then please hit the subscribe and click the notification bell. That's because I publish data-driven stock analysis like this every single week and these actions are the best way to ensure that you see what I publish next. Let's move on to Green Plains with the symbol of GPRE. This is one of the largest low-carbon fuel producers in North America and it's quietly transforming from a boom and bust ethanol maker into something far more durable. Uh they now run 10 biorefineries that turn corn into ethanol, high protein animal feed and renewable corn oil. Now for years, this is a business at the mercy of commodity prices. Prices swung wildly and the market treated it like nothing more than a gamble, which is kind of what it was for a long time. But Green Plains has been building out higher margin products and a brand new carbon capture operation that gets paid to lock away carbon dioxide, right? This means a steady high value revenue stream that does not bounce around with the price of corn. You can already see it in the earnings numbers. In fact, they're absolutely knocking out of the park, having completely beaten the tar out of estimates in eight to last four quarters. Now, some investors are starting to take notice given that the ample rising shares over the past year. Gladly, that party looks far from over. The reason I'm so optimistic is quite simple. Revenue is forecast to grow, get ready for this, five times faster than the industry average. And that translates into earnings growth, get ready for this, nine and a half times faster than it appears. Truly mind-blowing results on deck that should drive shares much, much higher. As you no doubt expect uh by now, this stock rates very highly in our Zen rating's quant model. And just like the past picks, it's A-rated. And just like the past two picks, it is in the top 1% of all stocks reviewed. The component grades reveal the fundamental superpowers of these shares. Now, we start with sentiment, which our smart money indicator in the top 16% of all stocks. Good to know the smart money is leaning in. Then we have growth in top 11%. That's the best predictor of more earnings beats ahead. Financial strength, top 6%. And as it should be in this video, the standout grade is value in the top 4%. As I'm sure you have noticed, an excellent value grade is something that the best stocks to buy in an overvalued market have in common. The risk to keep in mind is that ethanol margins still ride the commodity cycle. So, a bad stretch could certainly put pressure on their tremendous growth potential. Gladly, that higher margin carbon revenue is exactly the kind of ballast built to steady the ship over time. No doubt you see a pattern forming in this video. We want exceptional growth, great value, which leads to tremendous upside potential. Now, Plains certainly fits the bill. And for as appealing as that stock is and in the previous two we talked about, we still have two fantastic picks left to go. That brings us to Ironwood Pharmaceuticals with a symbol of IRWD. This is a commercial-stage healthcare company built around treatments for gastrointestinal conditions anchored by a franchise generating real durable revenue. Now, revenue is nice, profits are even nicer. And this company is ramping up to serious profit margins where more and more of every dollar of revenue falls straight to that bottom line. Yet, for all the growth in hand, for in as much as shares have already rallied today, it's still obscenely undervalued. This is best seen through the PEG ratio once again at 0.26. Now, here again, the average stock is trading for 1.5 times earnings. So, let me be clear about the math. Ironwood would have to rally about sixfold from here to match up with the average stock valuation. Yeah, it is that kind of obscene value that is at play with this stock. Wall Street has mostly looked the other way with only one analyst covering the stock. Gladly, it's worth noting who that is, and the person pounding the table is Jason Butler from Citizens, who ranks in the top 13% of all analysts based on his actual stock picking track record. Now, his fair value target calls for nearly 130% upside potential for shares in the year ahead. The Zen ratings confirms the bullish case for Ironwood. Yes, it's A-rated. This time scoring the top 3% of all stocks after that full 115 fundamental and technical factor review. That strength shows up in spades in the component grades. Its growth comes in the top 25%. This points to a more growth ahead. And then we have make a big leap in the top 1% for both financial strength and yes, for value. This really is the holy trinity of component grades as they are the most beneficial in finding stocks more likely to outperform in the months and years ahead. The one serious mark against this stock is their outsized debt load, but even with that on the books, they were still strong enough. Another key area is that they scored in the top 1% for financial strength, which includes a review of the debt. Here again, we have the growth and the value and the beneficial Zen rating of A, but now we add some welcome Wall Street support with a target price 130% above current levels. This pharma stock may be very good medicine for your portfolio. Before I move on to the last stock, I want to invite you to join me live every Monday. That's when I share my updated market outlook and trading plan to outperform. This is also where I unveil my trade of the week based upon the proven Zen Ratings Quant model and my greater than 40 years of investing experience. It's a free event, but you do need to register, so do that now by going to wallstreetzen.com/live or click the link in the description down below or scan the QR code on your screen, whichever side of me it's on. Just pause the video for a moment to sign up. I will be patient and wait for you. Then I look forward to seeing you there on Monday. Let's finish strong with another top stock. Now, I want you to picture the entire build-out of AI data centers and telecom networks and defense systems. Now, picture all the batteries and power systems keeping it all running when the grid goes down, which is a bit far too often these days. That brings us to EnerSys with the symbol ENS, the global leader in stored energy. They make the industrial batteries, chargers, and power equipment that sit behind the scenes of the economy, the unglamorous hardware that every data center and defense system quietly depends on when all else fails. Now, the AI build-out is pouring money into data centers like it's going out of style, and they need backup power that never blinks. EnerSys sells directly into that massive wave of demand, and business is good, like real good. In fact, EnerSys has beaten the absolute stuffing out of estimates for 19 quarters in a row, right? Five years of good times. The kind of consistency that's hard to fake. And if you look closely, the beats are getting even more impressive in the most recent quarters. Yes, other investors have taken notice with shares rallying close to 100% the past year, but it has recently pulled back nicely along with many AI-related names. Now, we can snap it up a much more attractive entry point. The Zen Ratings is also electrified by EnerSys. Yes, A-rated, and yes, in the top 1% of the 4,600 stocks analyzed by by the model. And yes, the component grades tells a story filled with an exciting blend of strengths. Our AI timeliness factor ranks in the top 20% of all stocks tracked. Growth is top 15%. Sentiment uh smart money top 9%. Value top 4%. In this case, the strongest one is financials in the top 1%. Now, what's not to like about that? Just like everyone else connected to AI spending, if that shows any signs of slowing then the whole group will be taken behind the woodshed and punished severely. But right now, all signs point north for AI CapEx spending where NSS should continue to benefit. On top of that, we have an elite Zen Rings profile and stellar value proposition that so greatly increases the odds of outside share price gains. So, there you have it. Five meaty bargains in a market star for value. A couple of these may not stay that cheap for long, so if any caught your eye, it is worth doing your homework now. And that's a good reminder the Zen Rings are updated daily. You can get that anytime for free on our quote pages at wallstreetzen.com. So, be sure to bookmark the site for all your future stock research needs. Now, I want to hear from you. Which of these five stocks do you like the most? And are there any other deep value stocks I didn't mention that belong in one of my future videos? Share it all with our community in the comments section below. And if you want to discover more hidden gems, I suggest you check out the uh four small caps featured in the video that's popping up on your screen right now.

Commentaires 0

Aucun commentaire pour l'instant. Soyez le premier à partager votre avis !